AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 152 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $190,000 | +86.3% | 64,100 | -6.6% | 0.00% | – |
| Q2 2016 | $102,000 | -61.1% | 68,600 | -3.1% | 0.00% | – |
| Q1 2016 | $262,000 | -65.5% | 70,800 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $759,000 | -25.7% | 75,100 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $1,021,000 | -53.6% | 75,100 | -35.3% | 0.00% | -33.3% |
| Q2 2015 | $2,202,000 | +19.0% | 116,100 | +54.6% | 0.00% | 0.0% |
| Q1 2015 | $1,850,000 | 0.0% | 75,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,850,000 | +136.0% | 75,100 | +219.6% | 0.00% | +200.0% |
| Q3 2014 | $784,000 | +4.0% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $754,000 | -40.2% | 23,500 | -22.1% | 0.00% | -50.0% |
| Q1 2014 | $1,261,000 | -72.1% | 30,158 | -53.3% | 0.00% | -66.7% |
| Q4 2013 | $4,519,000 | +112.6% | 64,513 | +160.1% | 0.01% | +50.0% |
| Q3 2013 | $2,126,000 | +96.3% | 24,800 | +45.0% | 0.00% | +100.0% |
| Q2 2013 | $1,083,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 4,656,682 | $399,310,000 | 16.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,300,000 | $111,475,000 | 5.48% |
| ADVENT INTERNATIONAL, L.P. | 705,300 | $60,479,000 | 5.01% |
| Antipodean Advisors LLC | 266,400 | $22,844,000 | 2.38% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 489,181 | $41,928,000 | 2.06% |
| HealthCor Management, L.P. | 425,000 | $36,444,000 | 1.95% |
| Cupps Capital Management, LLC | 290,489 | $24,909,000 | 1.62% |
| Zweig-DiMenna Associates LLC | 421,400 | $36,135,000 | 1.46% |
| SABBY MANAGEMENT, LLC | 259,119 | $22,209,000 | 1.44% |
| Independence Capital Asset Partners, LLC | 98,070 | $8,410,000 | 1.43% |